Journal Guide

Applied Health Economics and Health Policy is an international peer-reviewed journal designed to communicate the latest applied information in health economics and health policy.
Areas of interest include:  
• Economic analysis of all aspects of healthcare interventions.
• Economic analysis of health policy initiatives.
• Cost of illness studies.
• Evaluation of methodologies.
• Analysis of pricing and reimbursement systems.  

Cardiology and Therapy is a fully open access, internationally peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3-4 weeks from acceptance). Emphasis is placed on the publication of high-quality practical and clinical research around new and existing therapies in all areas of cardiology, including interventional cardiology. Studies relating to diagnosis, health economics, outcomes research, patient care, management, and education are also encouraged. The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, drug reviews, case reports, and short communications. Moving forward from traditional publishing, Cardiology and Therapy offers a range of additional features designed to increase visibility and readership. As such, each paper is accompanied by a bulleted slide summary giving a time-efficient overview of the content to a wider readership. All submissions have the option to include slide sets, video components, animations, and/or interactive case studies.Cardiology and Therapy publishes supplements and special issues (in English or a local language). Material appropriate for supplements/special issues include: sponsored meeting proceedings, roundtable discussions, workshop reports, case series, and collections of articles on the same topic. All articles are subject to peer review, and must adhere to the IJCME and GPP policies on acknowledgments/disclosures. Proposals for supplements are welcomed, and should be addressed to nicola.cartridge@springer.comFor authors: Upon acceptance of your article for publication, you will be required to pay the article open access fee of £175/€200/$260 per printed page. This will enable you to keep the copyright: you are simply assigning the exclusive right to any commercial use of the article to Springer. Your article will be immediately and permanently available with open, access.

Dermatology and Therapy is an open access, international, peer-reviewed, rapid-publication journal dedicated to the publication of cutting-edge research, treatment, and aesthetic interventions in dermatology.Emphasis is placed on articles that investigate the clinical aspects of dermatology, such as skin pharmacology:  skin development and aging, prevention, diagnosis, and management of skin disorders: and research into dermal structures and pathology. The journal also provides insights into all aspects relating to aesthetic dermatology, such as skin maintenance: photodamage and photoprotection: rejuvenation: restoration: and dermatological surgery and lasers. Pharmacoeconomic, epidemiological outcomes, and quality of life studies are also be encouraged, along with research relating to patient management.The journal is of interest to a broad audience of pharmaceutical and eye care professionals and publishes original research papers, drug reviews, case reports, and short communications.Moving forward from traditional publishing, Dermatology and Therapy offers a range of additional features designed to increase visibility and readership. Each paper is accompanied by a bulleted slide summary, giving a time-efficient overview of the content to a wider readership. Articles also have the option to include slide sets, videos, animations, and/or interactive case studies. The QR code on the front page of each article links readers back to the journal website to view these extra features.Dermatology and Therapy publishes supplements and special issues (in English or a local language). Material appropriate for supplements/special issues include: sponsored meeting proceedings, roundtable discussions, workshop reports, case series, and collections of articles on the same topic. All articles are subject to peer review, and must adhere to the IJCME and GPP policies on acknowledgments/disclosures. Proposals for supplements are, welcomed, and should be addressed to clare.shepherd@springer.comFor authors: Upon acceptance of your article for publication, you will be required to pay the article open access fee of £175/€200/$260 per printed page. This will enable you to keep the copyright: you are simply assigning the exclusive right to any commercial use of the article to Springer. Your article will be immediately and permanently available with open access.

 

Diabetes Therapy is an international, open access, peer-reviewed journal focused on cutting-edge research in the prevention, treatment, management, and education of diabetes and related disorders including obesity and metabolic syndromes. Emphasis is placed on the publication of high-quality articles covering preclinical, clinical (phase 1-4), and postmarketing studies on new and existing therapies and devices. Pharmacoeconomic, epidemiological, outcomes, and quality of life studies are also encouraged, along with research relating to patient management and education. The journal aims to promote better management and care of patients with diabetes and provides expert opinion on current advances in the field.Diabetes Therapy publishes original research, reviews, case reports, and short communications.Diabetes Therapy publishes supplements and special issues (in English or a local language). Material appropriate for supplements/special issues include: sponsored meeting proceedings, roundtable discussions, workshop reports, case series, and collections of articles on the same topic. All articles are subject to peer review, and must adhere to the IJCME and GPP policies on acknowledgments/disclosures. Proposals for supplements are welcomed, and should be addressed to nicola.cartridge@springer.comFor authors: Upon acceptance of your article for publication, you will be required to pay the article open access fee of £175/€200/$260 per printed page. This will enable you to keep the copyright: you are simply assigning the exclusive right to any commercial use of the article to Springer. Your article will be immediately and permanently available with open access.

Drugs - Real World Outcomes targets research involving the use of real-world data to evaluate health outcomes and inform healthcare decision-making, with a particular focus on healthcare-related 'big data'. Drugs - Real World Outcomes has a broad scope, encompassing studies investigating drug utilisation, patterns of prescribing, pharmacovigilance, treatment guideline adherence, benefit-risk assessments, comparative effectiveness and economic analyses.

Drugs in R&D is an international, peer reviewed, open access, online only journal, which provides timely information on emerging drug classes and new treatments for specific disorders in an ‘open access’ format for all to review. Original research and reviews from all phases of clinical development are included, with a strong link to clinical practice. Healthcare decision makers are thus provided with clinically applicable knowledge about the likely place in therapy of a drug.Journal issues comprise:·        Original research on new drugs, including clinical trials:·        New research on established drugs.·        R&D Insight reports:Short communications and letters to the editor are welcomed and will be considered for publication. Reviews may also be considered. All manuscripts are subject to peer review by international experts.

Infectious Diseases and Therapy is an open access, internationally peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3-4 weeks from acceptance). Emphasis is placed on high quality pre-clinical, clinical (phases 1-4), and real world research around the discovery,  development, and use of infectious disease therapies. The journal also encourages diagnostic,  pharmacoeconomic, public health, educational, and quality of life studies as well as research around the prevention and management of infectious disease. Areas of focus include, but are not limited to, chronic infections, vaccines, drug-resistant pathogens, microbiology, epidemiology, and tropical, emergent, and sexually-transmitted diseases.The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research papers, drug reviews, case reports, and short communications. Each paper is accompanied by a bulleted slide summary to give a time-efficient overview of the content. All submissions have the option to include slide sets, video components, animations, and/or interactive case studies.Infectious Diseases and Therapy publishes supplements and special issues (in English or a local language). Material appropriate for supplements/special issues include: sponsored meeting proceedings, roundtable discussions, workshop reports, case series, and collections of articles on the same topic. All articles are subject to peer review, and must adhere to the IJCME and GPP policies on acknowledgments/disclosures. Proposals for supplements are welcomed, and should be addressed to clare.shepherd@springer.comFor authors: Upon acceptance of your article for publication, you will be required to pay the article open access fee of £175/€200/$260 per printed page. This will enable you to keep the copyright: you are simply assigning the exclusive right to any commercial use of the article to Springer., Your article will be immediately and permanently available with open access.